- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x MAN: alpha-D-mannopyranose(Non-covalent)
MAN.2: 3 residues within 4Å:- Chain C: P.308, T.309
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.1
No protein-ligand interaction detected (PLIP)MAN.7: 3 residues within 4Å:- Chain D: P.308, T.309
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.6
No protein-ligand interaction detected (PLIP)MAN.12: 3 residues within 4Å:- Chain B: P.308, T.309
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.11
No protein-ligand interaction detected (PLIP)MAN.17: 3 residues within 4Å:- Chain A: P.308, T.309
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.16
No protein-ligand interaction detected (PLIP)- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
NAG.3: 2 residues within 4Å:- Chain A: N.64, W.356
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.64, A:W.356
NAG.4: 4 residues within 4Å:- Chain A: D.1, F.2, N.4, N.153
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:D.1
- Hydrogen bonds: A:D.1, A:F.2, A:N.4
NAG.8: 2 residues within 4Å:- Chain B: N.64, W.356
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.64, B:W.356
NAG.9: 4 residues within 4Å:- Chain B: D.1, F.2, N.4, N.153
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:D.1
- Hydrogen bonds: B:D.1, B:F.2, B:N.4
NAG.13: 2 residues within 4Å:- Chain C: N.64, W.356
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.64, C:W.356
NAG.14: 4 residues within 4Å:- Chain C: D.1, F.2, N.4, N.153
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:D.1
- Hydrogen bonds: C:D.1, C:F.2, C:N.4
NAG.18: 2 residues within 4Å:- Chain D: N.64, W.356
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.64, D:W.356
NAG.19: 4 residues within 4Å:- Chain D: D.1, F.2, N.4, N.153
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:D.1
- Hydrogen bonds: D:D.1, D:F.2, D:N.4
- 4 x ABW: 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]-2,5-ANHYDRO-3,4-DIDEOXY-4-(METHOXYCARBONYL)PENTONIC ACID(Non-covalent)
ABW.5: 15 residues within 4Å:- Chain A: R.36, E.37, L.52, D.69, R.70, R.74, W.97, R.143, A.165, E.195, E.196, R.211, N.213, R.289, Y.323
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:D.69, A:W.97, A:R.143, A:A.165, A:E.195
- Hydrogen bonds: A:R.70, A:E.196, A:Y.323
- Salt bridges: A:R.36, A:R.74, A:R.211, A:R.289
ABW.10: 15 residues within 4Å:- Chain B: R.36, E.37, L.52, D.69, R.70, R.74, W.97, R.143, A.165, E.195, E.196, R.211, N.213, R.289, Y.323
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:D.69, B:W.97, B:R.143, B:A.165, B:E.195
- Hydrogen bonds: B:R.70, B:E.196, B:Y.323
- Salt bridges: B:R.36, B:R.74, B:R.211, B:R.289
ABW.15: 15 residues within 4Å:- Chain C: R.36, E.37, L.52, D.69, R.70, R.74, W.97, R.143, A.165, E.195, E.196, R.211, N.213, R.289, Y.323
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:D.69, C:W.97, C:R.143, C:A.165, C:E.195
- Hydrogen bonds: C:R.70, C:E.196, C:Y.323
- Salt bridges: C:R.36, C:R.74, C:R.211, C:R.289
ABW.20: 15 residues within 4Å:- Chain D: R.36, E.37, L.52, D.69, R.70, R.74, W.97, R.143, A.165, E.195, E.196, R.211, N.213, R.289, Y.323
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:D.69, D:W.97, D:R.143, D:A.165, D:E.195
- Hydrogen bonds: D:R.70, D:E.196, D:Y.323
- Salt bridges: D:R.36, D:R.74, D:R.211, D:R.289
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, G.T. et al., Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core. Bioorg.Med.Chem.Lett. (2005)
- Release Date
- 2005-01-11
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x MAN: alpha-D-mannopyranose(Non-covalent)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 4 x ABW: 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]-2,5-ANHYDRO-3,4-DIDEOXY-4-(METHOXYCARBONYL)PENTONIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, G.T. et al., Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core. Bioorg.Med.Chem.Lett. (2005)
- Release Date
- 2005-01-11
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A